Clinical trial

Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy

NCT00574405

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-04-01

PhaseNA

Study timeline

Study start (unknown)2005-04-01Date precision: month

Registry last updated2017-09-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

MDI (split-mix NPH insulin + regular insulin or Lantus + Novolog® [or Humalog®])DRUG

CSII (Animas Corporation insulin pump, model IR 1200)DEVICE

Sponsors & collaborators

Arkansas Children's Hospital Research Institutelead sponsor

Mapped research locations

Little RockArkansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00574405 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.